Clinical Report: Inflammatory Processes in Myocarditis: Mechanisms and Targets

Overview

Myocarditis is an inflammatory disease influenced by immune responses, leading to varied clinical outcomes. The review highlights the role of inflammation in disease progression.

Background

Myocarditis is characterized by inflammation of the myocardium, which can lead to severe outcomes such as dilated cardiomyopathy and heart failure. Understanding the underlying inflammatory mechanisms is crucial for improving diagnosis and treatment strategies. Recent research emphasizes the importance of both innate and adaptive immune responses in the pathogenesis of myocarditis.

Data Highlights

No specific numerical or trial data provided in the article.

Key Findings

• Myocarditis can result from various infectious and non-infectious causes, with viral infections being the most common.
• Pathogen- and damage-associated molecular patterns activate immune responses, leading to myocardial injury.
• Dysregulation of immune responses, including Th1/Th2 imbalance, contributes to persistent inflammation and fibrosis.
• Emerging biomarkers may aid in risk stratification and monitoring of myocarditis.
• Targeted immunomodulatory strategies are under investigation to prevent chronic inflammation and adverse remodeling.

Clinical Implications

Clinicians should consider the role of inflammation in myocarditis when diagnosing and managing patients.

Conclusion

A deeper understanding of the inflammatory processes in myocarditis is essential for developing targeted therapies and improving patient outcomes.

Related Resources & Content

1. Frontiers in Cardiovascular Medicine, 2026 -- Targeting the heart-immune axis after myocardial infarction: from inflammation to immunomodulation
2. Basic Research in Cardiology, 2013 -- Addressing Inflammation in Heart Failure: A Translational Approach to Healing an Inflamed Heart
3. Frontiers in Immunology, 2026 -- Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk
4. Basic Research in Cardiology — Molecular Signatures of Cardiovascular Toxicity Linked to Immune Checkpoint Inhibitors
5. 2025 ESC Guidelines for the management of myocarditis and pericarditis
6. ACC ECDP for Diagnosis and Management of Myocarditis: Key Points
7. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study | European Heart Journal | Oxford Academic
8. Intravenous immunoglobulin for presumed viral myocarditis in children and adults - PMC
9. https://www.jstage.jst.go.jp/article/ihj/advpub/0/advpub_18-299/_pdf
10. Giant cell myocarditis - PMC
11. Steroids in Immune Checkpoint Inhibitor Myocarditis | JACC: CardioOncology